131 related articles for article (PubMed ID: 21146886)
1. Association between polymorphisms in RAPGEF1, TP53, NRF1 and type 2 diabetes in Chinese Han population.
Qu L; He B; Pan Y; Xu Y; Zhu C; Tang Z; Bao Q; Tian F; Wang S
Diabetes Res Clin Pract; 2011 Feb; 91(2):171-6. PubMed ID: 21146886
[TBL] [Abstract][Full Text] [Related]
2. RAPGEF1 gene variants associated with type 2 diabetes in the Korean population.
Hong KW; Jin HS; Lim JE; Ryu HJ; Go MJ; Lee JY; Woo JT; Park HK; Oh B
Diabetes Res Clin Pract; 2009 May; 84(2):117-22. PubMed ID: 19297053
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive association study of type 2 diabetes and related quantitative traits with 222 candidate genes.
Gaulton KJ; Willer CJ; Li Y; Scott LJ; Conneely KN; Jackson AU; Duren WL; Chines PS; Narisu N; Bonnycastle LL; Luo J; Tong M; Sprau AG; Pugh EW; Doheny KF; Valle TT; Abecasis GR; Tuomilehto J; Bergman RN; Collins FS; Boehnke M; Mohlke KL
Diabetes; 2008 Nov; 57(11):3136-44. PubMed ID: 18678618
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation and association analyses of the nuclear respiratory factor 1 (nRF1) gene in Chinese patients with type 2 diabetes.
Liu Y; Niu N; Zhu X; Du T; Wang X; Chen D; Wu X; Gu HF; Liu Y
Diabetes; 2008 Mar; 57(3):777-82. PubMed ID: 18071027
[TBL] [Abstract][Full Text] [Related]
5. Association study between the TP53 Rs1042522G/C polymorphism and susceptibility to systemic lupus erythematosus in a Chinese Han population.
Yang J; Zhu JM; Wu S; Li J; Wang MR; Wang TT; Lu YW
Rheumatol Int; 2017 Apr; 37(4):523-529. PubMed ID: 28184992
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in TP53 are associated with risk and survival of osteosarcoma in a Chinese population.
Ru JY; Cong Y; Kang WB; Yu L; Guo T; Zhao JN
Int J Clin Exp Pathol; 2015; 8(3):3198-203. PubMed ID: 26045840
[TBL] [Abstract][Full Text] [Related]
7. The
He J; Wang F; Zhu J; Zhang Z; Zou Y; Zhang R; Yang T; Xia H
Aging (Albany NY); 2017 Mar; 9(3):852-859. PubMed ID: 28275206
[No Abstract] [Full Text] [Related]
8. Relationship between TP53 and interleukin-6 gene variants and the risk of types 1 and 2 diabetes mellitus development in the Kermanshah province.
Haghnazari L; Sabzi R
J Med Life; 2021; 14(1):37-44. PubMed ID: 33767783
[TBL] [Abstract][Full Text] [Related]
9. The functional TP53 rs1042522 and MDM4 rs4245739 genetic variants contribute to Non-Hodgkin lymphoma risk.
Fan C; Wei J; Yuan C; Wang X; Jiang C; Zhou C; Yang M
PLoS One; 2014; 9(9):e107047. PubMed ID: 25203442
[TBL] [Abstract][Full Text] [Related]
10. Studies of the association of Arg72Pro of tumor suppressor protein p53 with type 2 diabetes in a combined analysis of 55,521 Europeans.
Burgdorf KS; Grarup N; Justesen JM; Harder MN; Witte DR; Jørgensen T; Sandbæk A; Lauritzen T; Madsbad S; Hansen T; ; Pedersen O
PLoS One; 2011 Jan; 6(1):e15813. PubMed ID: 21283750
[TBL] [Abstract][Full Text] [Related]
11. Association of
Liao F; Yuan L; Zhu J; Chen W; Zhao Y; He J
Biomed Res Int; 2022; 2022():2712808. PubMed ID: 35996546
[TBL] [Abstract][Full Text] [Related]
12. TP53 Arg72Pro polymorphism (rs1042522) and risk of endometriosis among Asian and Caucasian populations.
Li J; Chen Y; Mo Z; Li L
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():73-8. PubMed ID: 25889195
[TBL] [Abstract][Full Text] [Related]
13.
Liu P; Zhuo Z; Li W; Cheng J; Zhou H; He J; Zhang J; Wang J
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30610160
[TBL] [Abstract][Full Text] [Related]
14. TP 53 polymorphisms and melanoma: A meta-analysis.
He T; Wu J; Chen Y; Zhang J
J Cancer Res Ther; 2015; 11(2):409-14. PubMed ID: 26148609
[TBL] [Abstract][Full Text] [Related]
15. Association of TP53 rs1042522 C>G and miR-34b/c rs4938723 T>C polymorphisms with hepatoblastoma susceptibility: A seven-center case-control study.
Liu P; Zhuo ZJ; Zhu J; Yang Z; Xin Y; Li S; Li L; Li Y; Wang H; He J
J Gene Med; 2020 Jul; 22(7):e3182. PubMed ID: 32166848
[TBL] [Abstract][Full Text] [Related]
16. TP53 genetic polymorphisms, interactions with lifestyle factors and lung cancer risk: a case control study in a Chinese population.
Li Y; Chang SC; Niu R; Liu L; Crabtree-Ide CR; Zhao B; Shi J; Han X; Li J; Su J; Cai L; Yu S; Zhang ZF; Mu L
BMC Cancer; 2013 Dec; 13():607. PubMed ID: 24369748
[TBL] [Abstract][Full Text] [Related]
17. Association between TP53 rs1042522 gene polymorphism and the risk of malignant bone tumors: a meta-analysis.
Huang X; Wu F; Zhang Z; Shao Z
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30833364
[No Abstract] [Full Text] [Related]
18. Common genetic variants in 53BP1 associated with nonsmall-cell lung cancer risk in Han Chinese.
Zhang H; Hao S; Zhao J; Zhou B; Ren Y; Yan Y; Zhao Y
Arch Med Res; 2014 Jan; 45(1):84-9. PubMed ID: 24316395
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D
Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of TP53 are markers of bladder cancer vulnerability and prognosis.
Lin HY; Yang MC; Huang CH; Wu WJ; Yu TJ; Lung FW
Urol Oncol; 2013 Oct; 31(7):1231-41. PubMed ID: 22178231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
